Introduction {#sec1-1}
============

Congenital heart disease (CHD) is an important cause of death during the 1^st^ year of life and includes a specific group of cardiac diseases that exist from birth. Usually, these conditions arise due to the abnormal development of an embryo\'s normal structures and/or the cessation of their maturity during the early stages of embryonic development. The leading cause of neonatal death from congenital anomalies is congenital heart defects. A third of deaths resulting from anomalies are related to CHD, encompassing one-tenth of all neonatal deaths). Twenty-five to thirty percent of beds occupied in the pediatric ICU are by children with CHD. Thus, a great portion of healthcare costs is spent on these diseases.\[[@ref1]\]

The causes of most CHDs remain unknown. Mostly, they are multifactorial and result from a combination of genetic and environmental factors. A small percentage of CHD is related to chromosomal abnormalities, especially trisomies 18, 13, 21 and Turner\'s Syndrome.\[[@ref2][@ref3]\]

The genetic background of CHD incidence among the healthy population is approximately 0.8%. Two to four percent of CHD cases are related to environmental or maternal conditions and teratogenic effects, including, maternal diabetes mellitus, maternal phenylketonuria, maternal lupus, congenital rubella syndrome, and the intake of drugs (lithium, ethanol, warfarin, thalidomide, Vitamin "A" derivatives, sodium valproate, carbamazepine, antimetabolites).\[[@ref2][@ref3][@ref4]\]

The number of newborns with CHD in Qom is high, of which there is no precise estimate of them. Moreover, the costs of treating these children and their mortality rates are also high. Hence, the research team attempted to identify the causes of its occurrence, the information with which we can help reduce its risk factors, its patients, and its mental, social and economic burdens on the families and society.

Materials and Methods {#sec1-2}
=====================

A case--control study was conducted in which the case group included newborns with CHD, and the control group included newborns without CHD. The aforementioned all newborns were admitted to Hazrat Masoumeh Hospital\'s Heart Clinic. Convenience sampling was used to select the controls, and simple random sampling was used to select the cases. Moreover, the two groups were homogenous in terms of age and sex. Based on the following equation, approximately 221 individuals were selected for each group, totaling 442 persons.

Variables under study were CHD, maternal age, family marriage, family history (FH), maternal diabetes, obesity, cigarette smoking, antiepileptic use, folic acid use, maternal rheumatologic diseases, and educational status.

Data were gathered through questionnaires and interviews with the mothers after birth; their medical records were also collected.

The statistical software of SPSS version 23 for windows (SPSS Inc., Chicago, IL, USA) was employed to analyze the data. Descriptive analytics such as mean, standard deviation, and frequency of the quantitative and qualitative variables were computed. The Chi-square test was used to examine the association between the variables. Logistic regression was also applied.

Results {#sec1-3}
=======

The mean maternal age was 28.48 and 28.62 years in the case and control groups, respectively. The mean body mass index (BMI) in the case and control groups was 28.95 and 27.93, respectively.

No significant association was observed between \<20 and 35\< years of maternal age and CHD in the newborn (χ^2^ = 4.46, *P* = 0.11) \[[Table 1](#T1){ref-type="table"}\].

###### 

Comparing the association between maternal age and congenital heart disease in both groups

![](JEHP-7-53-g001)

There was no significant association between maternal BMI and birth of a baby with CHD (χ^2^ = 2.70, *P* = 0.44) \[[Table 2](#T2){ref-type="table"}\].

###### 

Comparing the association between maternal obesity and congenital heart disease in both groups

![](JEHP-7-53-g002)

There was a statistically significant association between CHD and consanguineous marriage (χ^2^ = 14, *P* \< 0.001) \[[Table 3](#T3){ref-type="table"}\].

###### 

Comparing the association between consanguineous marriage and congenital heart disease in both groups
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There was a statistically significant association between CHD and a positive FH (χ^2^ = 12.10, *P* \< 0.001) \[[Table 4](#T4){ref-type="table"}\].

###### 

Comparing the association between a positive family history and congenital heart disease in both groups

![](JEHP-7-53-g004)

There was a statistically significant association between CHD and maternal diabetes (χ^2^ = 8.13, *P* = 0.004) \[[Table 5](#T5){ref-type="table"}\].

###### 

Comparing the association between maternal diabetes and congenital heart disease in both groups
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There was no statistically significant association between CHD and cigarette smoking by the mother during the first 45 days of gestation (χ^2^ = 0.15, *P* = 0.7) \[[Table 6](#T6){ref-type="table"}\].

###### 

Comparing the association between cigarette smoking by the mother and congenital heart disease in both groups

![](JEHP-7-53-g006)

There was a statistically significant association between CHD and the mother\'s educational status (χ^2^ = 17.80, *P* \> 0.001) \[[Table 7](#T7){ref-type="table"}\].

###### 

Comparing the association between the mother\'s educational status and congenital heart disease in both groups

![](JEHP-7-53-g007)

There was a statistically significant association between CHD and antiepileptic use by the mother during the first 45 days of gestation (χ^2^ = 9.30, *P* = 0.002) \[[Table 8](#T8){ref-type="table"}\].

###### 

Comparing the association between antiepileptic use by the mother and congenital heart disease in both groups

![](JEHP-7-53-g008)

There was a statistically significant association between CHD and the lack of folic acid use by the mother during the first 45 days of gestation (χ^2^ = 5.70, *P* = 0.017) \[[Table 9](#T9){ref-type="table"}\].

###### 

Comparing the association between folic acid used by the mother and congenital heart disease in both groups

![](JEHP-7-53-g009)

There was no statistically significant association between CHD and maternal rheumatologic diseases (χ^2^ = 0.71, *P* = 0.40) \[[Table 10](#T10){ref-type="table"}\].

###### 

Comparing the association between maternal rheumatologic diseases and congenital heart disease in both groups

![](JEHP-7-53-g010)

Discussion {#sec1-4}
==========

The aim of this study was to determine the indices related to CHD in Qom province. In this study, maternal age, maternal education, maternal anticonvulsant therapy, rheumatologic disease, smoking, familial marriage, and familial FH of CHD. In two groups, case and control groups were examined. The case group included newborns with CHD diagnosed in echocardiography, and the control group consisted of newborns without CHD were selected from newborns referring to Hazrat Masoumeh Hospital\'s Heart Clinic.

This study showed that positive familial history, familial marriage, maternal diabetes, lack of folic acid during pregnancy, use of anticonvulsants, and maternal education with CHD have a significant relationship. On the other hand, the study suggested that there was no significant relationship between maternal age, maternal BMI, smoking in the first 45 days of pregnancy, and maternal rheumatologic abnormalities with cardiac abnormalities in the newborn.

In two studies conducted by Tandon *et al*. and Ul Haq *et al*., several indicators of CHD in newborns were examined and found that there is a relationship between familial marriage and a positive FH of CHD with CHD, which is similar to the current study. However, in the study of Tandon *et al*., contrary to the current study, there was a significant relationship between the incidence of CHD disease with the parental age index during pregnancy.\[[@ref5][@ref6]\]

Kuciene and Dulskiene, Øyen *et al*., and Fung *et al*. studied the indices related to CHD and like the current study suggested relationship between maternal disease such as diabetes and positive FH with the incidence of the CHD. However, there was a significant relationship between maternal BMI with CHD; this is a different result from our study.\[[@ref7][@ref8][@ref9]\]

Roodpeyma *et al*. studied the risk factors of CHD in the Taleghani Hospital and observed that although CHD was associated with extracardiac anomalies and chromosomal disorders, maternal diseases, drugs used during the first trimester, history of abortion, and stillbirth did not have any proven effects on CHD occurrence, which was completely different from the current study and previous foreign studies.\[[@ref10]\]

We had some limitations in this study including parents' lack of cooperation to participate and using a questionnaire that is not free of errors. This study was conducted for the first time in Qom province to determine the factors affecting CHD.

Conclusions {#sec1-5}
===========

According to the results of this study and foreign studies conducted that familial marriage, positive family history, maternal diabetes, lack of folic acid, and anticonvulsant drug use during pregnancy are associated with CHD. Moreover, it shows the need for further study with larger volumes in the country to evaluate the risk factors associated with CHD to reduce the economic and social damage.

Limitation {#sec2-1}
----------

On the other hand, the good feature of this study is the previous study in this regard, the study over the period of 5 years and the higher number of samples in this study than others.
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